Emerge Australia's InfoLine

Emerge Australia offers a free, national InfoLine service for the ME/CFS community, including our members, anyone living with ME/CFS, their carers and healthcare practitioners.

The InfoLine is available during business hours Monday to Friday, for the ME/CFS community to ask questions, seek information and connect with us.

Common queries include:

information about ME/CFS
support group information (in-person and online) around Australia
telehealth nurse service information and bookings
general advice
membership information
GP Education promotion materials
financial literacy resources for NDIS or DSP applications
donations

Get in touch with our helpful team today to connect, learn more and share your experience. If we are unable to answer your question or provide support, we will make a referral to a service who can.

You can contact the InfoLine on 1800 865 321 or email us - send emails to [email protected]

Contacting Emerge Australia

Please contact Emerge Australia on 03 9529 1344 or email us [email protected] for all other general enquiries including:

media and speaking requests
partnership opportunities
fundraising proposals
bequests
research collaborations
events and conferences

Latest

A huge thank you to Dr Heidi Nicholl

The CEO of Emerge Australia, Dr Heidi Nicholl, has today announced her resignation after more than 3 years in the role.
Research Digest 26/03/21

Welcome to the 66th edition of the Research Digest featuring a study investigating the potential of measuring circulating levels of FGF21 and NT-proBNP as diagnostic biomarkers for ME/CFS.
Research Interview: Professor Ken Walder

Join us for an interview with Deakin University’s Chair In Metabolic Diseases, Prof Ken Walder about his recent work in ME/CFS research.
Research Digest 12/03/21

Welcome to the 65th edition of the Research Digest. This fortnight's edition features a study examining predicting factors of severe versus non-severe ME/CFS and a proteome study.

Open Medicine Foundation Australia

Emerge Australia is proud to be launching the 5th addition to a global network of OMF-established Research Collaboration, with our partner, Open Medicine Foundation, seeing an Australian collaboration to join with those at Harvard, Stanford, Uppsala, and Montreal universities.
Australian Research Centre to Open Early in 2021

The new Australian ME/CFS Centre for Collaborative Research is expected to officially open early in 2021
Research Digest 30/10/20

Welcome to the 58th edition of the Research Digest featuring a focus group study that aimed to gain insight into the PEM experiences of ME/CFS patients and a cluster analysis study defining subgroups of patients based on several measures of autonomic dysfunction.
Research Digest 04/09/20

Welcome to the 54th edition of the Research Digest. This fortnight's edition includes summary of a functional MRI study exploring brain responses to autonomic challenges in ME/CFS patients with and without temporomandibular disorder.
Coronavirus and ME - Simplified facts

Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.
Research Digest 26/03/21

Welcome to the 66th edition of the Research Digest featuring a study investigating the potential of measuring circulating levels of FGF21 and NT-proBNP as diagnostic biomarkers for ME/CFS.
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
What is fibromyalgia?

Fibromyalgia is an associated condition of ME/CFS
Research Digest 13/11/20

Welcome to the 59th edition of the Research Digest. This issue features a review article on the eitology of ME/CFS and a systematic review of neuroimaging studies.
Research Digest 16/10/20

Welcome to the 57th edition of the Research Digest featuring the results of the NHMRC ME/CFS Targeted Call for Research funding and a study that aimed to compare the subjective severity scoring of the SF-36 (based on the physical activity subscale) to two objective measures of activity in order to validate the way in which clinical severity is graded in ME/CFS.